Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.

[1]  G. Liang,et al.  Insig Proteins Mediate Feedback Inhibition of Cholesterol Synthesis in the Intestine* , 2013, The Journal of Biological Chemistry.

[2]  Jennifer G. Robinson,et al.  Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome. , 2013, Journal of clinical lipidology.

[3]  K. Hara,et al.  Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes. , 2013, Saudi medical journal.

[4]  Ian M Adcock,et al.  Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[5]  L. Deiana,et al.  Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy , 2012, Amino Acids.

[6]  S. Kahn,et al.  Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity. , 2011, American Journal of Clinical Nutrition.

[7]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[8]  M. Kostapanos,et al.  Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative Stress , 2011, Lipids.

[9]  S. Yamashita,et al.  Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. , 2010, Journal of atherosclerosis and thrombosis.

[10]  L. Buhler,et al.  Expression of the hepatic Niemann–Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes , 2010, Pharmacogenetics and genomics.

[11]  Hirokazu Takahashi,et al.  Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  S. Yoshida,et al.  Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia. , 2010, Journal of atherosclerosis and thrombosis.

[13]  G. Watts,et al.  Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet , 2010, Diabetes Care.

[14]  R. Morishita,et al.  Vascular protective effects of ezetimibe in ApoE-deficient mice. , 2009, Atherosclerosis.

[15]  M. Landray,et al.  Analyses of cancer data from three ezetimibe trials. , 2008, The New England journal of medicine.

[16]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[17]  M. Endres,et al.  Vascular effects of diet supplementation with plant sterols. , 2008, Journal of the American College of Cardiology.

[18]  B. Lamarche,et al.  Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes Published, JLR Papers in Press, March 3, 2007. , 2007, Journal of Lipid Research.

[19]  D. Landry,et al.  Sitosterol-containing Lipoproteins Trigger Free Sterol-induced Caspase-independent Death in ACAT-competent Macrophages* , 2006, Journal of Biological Chemistry.

[20]  Liqing Yu,et al.  Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice , 2006, Hepatology.

[21]  T. Strandberg,et al.  Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study. , 2006, Journal of the American College of Cardiology.

[22]  H. Gylling,et al.  Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. , 2005, Journal of the American College of Cardiology.

[23]  M. Laakso,et al.  Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300368-JLR200 , 2004, Journal of Lipid Research.

[24]  Luquan Wang,et al.  Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .

[25]  H. Gylling,et al.  Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment , 2003, European journal of clinical investigation.

[26]  H. Gylling,et al.  Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. , 2003, The Journal of laboratory and clinical medicine.

[27]  T. Sudhop,et al.  Serum plant sterols as a potential risk factor for coronary heart disease. , 2002, Metabolism: clinical and experimental.

[28]  D. Tribble,et al.  Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans , 2002, Circulation.

[29]  Ira Tabas,et al.  Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. , 2002, The Journal of clinical investigation.

[30]  S. Racette,et al.  Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. , 2002, The American journal of clinical nutrition.

[31]  H. Gylling,et al.  Introducing a new component of the metabolic syndrome: low cholesterol absorption. , 2000, The American journal of clinical nutrition.

[32]  B. Levy,et al.  Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. , 2000, Genomics.

[33]  R J Glynn,et al.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.

[34]  M. Maekawa,et al.  Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. , 1994, Biochimica et biophysica acta.

[35]  H. Kempen,et al.  Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.

[36]  H. Gylling,et al.  Low synthesis and high absorption of cholesterol characterize type 1 diabetes. , 2004, Diabetes care.